Enhertu Could Get Big Boost From Second-Line Breast Cancer Indication

 
• By Alaric DeArment
  
Doctor with Mammography - Image
AstraZeneca and Daiichi Sankyo announced positive topline results for Enhertu in second-line breast cancer • Source: Shutterstock

More from Clinical Trials

More from R&D